Rockwell Medical (RMTI) Reports Q4 Loss, Tops Revenue Estimates

Core Insights - Rockwell Medical reported a quarterly loss of $0.02 per share, matching the Zacks Consensus Estimate, compared to earnings of $0.02 per share a year ago [1] - The company posted revenues of $24.67 million for the quarter ended December 2024, exceeding the Zacks Consensus Estimate by 9.09% and up from $22.09 million year-over-year [3] Financial Performance - The quarterly report reflects an earnings surprise of -200%, following a previous quarter where the company had a positive surprise of 400% [2] - Over the last four quarters, Rockwell Medical has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2][3] Stock Performance - Rockwell Medical shares have declined approximately 13.7% since the beginning of the year, while the S&P 500 has decreased by 3.5% [4] - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $20.2 million, and -$0.03 on revenues of $87.63 million for the current fiscal year [8] Industry Outlook - The Medical - Products industry, to which Rockwell Medical belongs, is currently ranked in the bottom 49% of over 250 Zacks industries, indicating potential challenges ahead [9] - The performance of Rockwell Medical's stock may be influenced by the overall outlook for the industry [9]